Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 194–195 (2008)Cite this article

boxed-textRiddle M et al. (2007) Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin. Diabetes Care 30: 2794–2799

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Edelman SV and Henry RR (2006) Diagnosis and management of type 2 diabetes, edn 7, 237–252. Greenwich, CT: Professional Communications Inc.

    Google Scholar 

  2. Hollander PA et al. (2003) Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 26: 784–790

    Article  CAS  Google Scholar 

  3. Hollander P et al. (2004) Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. Obes Res 12: 661–668

    Article  CAS  Google Scholar 

  4. Edelman SV et al. (2006) Pramlintide in the treatment of diabetes. Int J Clin Pract 60: 1647–1653

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Endocrinology and Metabolism, VA San Diego Healthcare Center, 3350 La Jolla Village Drive (111G), San Diego, CA 92161, USA svedelman@vapop.ucsd.edu

Authors and Affiliations

  1. SV Edelman is a Professor of Medicine at the University of California–San Diego and Director of the Diabetes Care Clinic at Veteran's Affairs Medical Center, San Diego, CA, USA.,

    Steven V Edelman

Authors
  1. Steven V Edelman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Steven V Edelman is a member of the Speaker's bureau and a consultant for Amylin, Eli Lilly, Novo Nordisk, and Sanofi-Aventis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edelman, S. Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus?. Nat Rev Endocrinol 4, 194–195 (2008). https://doi.org/10.1038/ncpendmet0760

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0760

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing